In this paper we describe the effect of depletion of splenic macrophages on the uptake, and immune response against, different formulations of rabies virus antigen. Splenic macrophages were removed by intravenous injection with clodronate liposomes. ,B-propiolacton inactivated rabies virus (RV-BPL) and immune-stimulating complexes (iscom) containing these antigens were given to macrophage-depleted and control mice. In the absence of phagocytic cells in the spleen, antigen is still trapped in the red pulp and to a lesser extent in the peri-arteriolar lymphocyte sheaths (PALS) for both antigen formulations. The localization pattern in the main area of immune response induction, namely the follicles, was unaltered after macrophage depletion. Functionally, the depletion of splenic and liver macrophages had no influence on the induction of specific antibody responses in both RV-BPL or RV-iscom immunized mice, even though the latter presentation form was clearly associated with specific localization in the marginal metallophillic macrophages. In RV-BPL immunized mice, macrophage depletion had no influence on proliferative T-cell responses. However, macrophage-depleted mice that were immunized with RViscom showed a significant decrease in proliferative T-cell responses. These results confirm existing ideas on the spleen as a physical filter rather than an induction site for humoral responses and shed new light on the efficient role of iscoms as antigen-presenting moieties in relation to their specific in vivo localization patterns and partial macrophage dependency.
INTRODUCTION
Several mechanisms have been postulated to explain the relatively high immunogenicity of antigens presented in immunestimulating complexes (iscoms)."2 Their potency can in part be explained by the specific targeting of these structures to antigen-presenting cells (APC) of the immune system. Recently we developed a novel method for the in situ detection of iscoms. 3 Employing this technique we demonstrated that iscoms containing rabies virus antigen were taken up by a different subset of macrophages in the spleen than inactivated rabies virus antigen, thereby possibly explaining the difference in immunogenicity. Furthermore, we found a surprising preference for iscom, rather than intact virus, in the follicular trapping/uptake of these antigens. These results led to a biphasic presentation model for iscom with a specific localization pattern in marginal metallophilic macrophages (MMM), away from antigen-degrading macrophages, in the first phase and direct presentation to follicular cells in the second phase. This model implies an entire or at least partial dependency of the iscom-induced immune response on this particular macrophage subset. From several studies it has now become evident that the spleen processes antigen in two possible ways, depending on different types of non-lymphoid cells. Firstly, there seems to be a macrophage-dependent pathway for particulate-and thymus-independent type 1 fmitogenic polysaccharides) antigens. 4 (Fig. la) and proved alternating sections from those shown in Fig. 1 (data not  shown) . Irrespective of this complete absence of macrophages from the spleen, a massive trapping and retention of DiIlabelled RV-BPL could be observed (irrespective of the dose given). Contrary to the discrete localization pattern found in normal or PBS treated mice (in MZM and red pulp), RV-BPL seemed to be evenly distributed over all splenic compartments (Fig. lb) .
As described before,' iscom was taken up preferentially by MMM (bright yellow dots in Fig. lc) and to a lesser extent by MZM and on cells in the follicles. In macrophage-depleted animals iscom was trapped and retained almost exclusively in the marginal zone and red pulp of the spleen (irrespective of the dose given). Contrary to RV-BPL almost no iscom localization could be observed in the PALS area of depleted animals (Fig. Id) .
Immunological responses after depletion of spleen macrophages
Based on dose-response curves generated before3 we chose for similarity of eventual titre rather than dose of immunization (antigen). In this scenario 1 jg of RV-iscom is equivalent to 10 jg of RV-BPL, both resulting in virus neutralising antibodies, specific T cells and 100% survival after challenge (i.e. full protection). 3 Rabies-virus-specific antibody responses in serum were measured weekly in antigen-specific ELISA. Serum samples were analysed weekly after depletion of splenic macrophages and subsequent immunization to observe possible effects caused by macrophage repopulation of the spleen. It was established that at day 7 no repopulation of the spleen with macrophages has yet occured, marginal metallophils reappear between 14 and 21 days and at day 28 the normal situation is almost completely restored (4.6,17 and data not shown). As is shown in Fig. 2(a) (represenative experiment from three performed) no difference in the kinetics of the antibody response could be observed when splenic macrophages were removed in RV-iscom immunized animals as compared with untreated animals. It should be noted that a trend towards higher titers in depleted RV-BPL animals could be observed (not significant).
The clodronate treatment was repeated at day 40 and animals were booster immunized with RV-iscom at day 42. Both treated and untreated animals showed increased serum titres at 7 days after boost immunization as compared to primary responses. Again, no effect of the clodronate liposome treatment was observed. Identically, humoral responses after immunization with RV-BPL were unaffected after clodronate liposome treatment.
Proliferative splenocyte responses in RV-BPL immunized animals were unaffected after treatment with clodronate liposomes (Fig. 2c) . However, when splenic macrophages were removed prior to immunization with RV-iscom a significant decrease in rabies-virus-specific spleen-cell responses could be observed (Fig. 2d) Furthermore, CTL responses induced by membranous vesicles but not those induced by syngeneic antigen pulsed splenocytes proved to be macrophage dependent23. Iscom and inactivated virus can be regarded as hydrophobic particulate antigens. In this study no differences in humoral response were observed in macrophage-depleted cells as compared with untreated animals, at the antigen dose and immunization regime studied. In view of the finding that trapping of both antigens occurs on follicular cells in depleted animals it can be concluded that follicular dendritic or follicular B cells are involved in antigen presentation of both RV-BPL and iscom. This observation, in combination with the observed decrease in T-cell responses against iscom in depleted animals, suggests a role for both follicular cells and MMM in the presentation of iscom. And no or very limited role for MMM in the presentation of RV-BPL.
To induce an efficient MHC class I restricted immune response, involving the production of antigen specific cytotoxic T-cells (CTL), it seems necessary to target the antigen to the cytoplasm29 or induce processing by dedicated macrophages2224. It CTL response which is dependent on the presence of macrophages. Such a decrease has been described for the generation of primary ovalbumin (OVA)-specific CTL after splenic macrophage elimination.29 Why this decrease does not occur in RV-BPL immunized animals, which normally generate CTL activity as well, remains unclear but, in combination with the localization data, it suggests a role for the MMM subset in the (pre)processing of antigen in iscom and not in other unactivated antigen forms. Removal of splenic and hepatic macrophages with clodronate liposomes is very efficient and actually eliminates phagocytic cells from the tissues altogether.'6 As described before in studies using radioactively labelled liposomes"0 this removal does not result in persistently increased serum levels of the antigen nor in a decrease of splenic uptake or a change of antigen localization patterns. The present results show the localization patterns of this nonphagocytic trapping by the spleen. As observed for a soluble thymus-independent antigen' it is evident that antigen is still trapped by follicular (dendritic or B) cells of the spleen after macrophage depletion. In view of the crucial role of dendritic cells29 and follicular dendritic cells in the presentation of antigens to the immune system3'5 this is an important observation. Furthermore, this is in accordance with the primary function of the spleen, namely as a filter of the blood.4'5 In a large number of studies it has now been shown that removal of marginal zone macrophages leads to a relative increase of humoral immune responses against particulate antigens17 or antigens in oil emulsions.3' This trend is also visible in this study (Fig. 2b) . The preferential localization of iscom in MMM certainly leads to relative protection of the antigen for the degradable action of marginal zone macrophages and provides an explanation for the relative effectiveness (10-25-fold efficiency gain in terms of dose3) of iscom in inducing immune responses. Studies involving development or optimization of iscom or other antigen presenting moieties should therefore include similar in vivo localization and modulation studies to better predict eventual efficacy. This in turn will lead to vaccines with higher efficacy at much lower antigen concentrations because much less antigen is lost by immunologically non-specific filtering.
